InvestorsHub Logo
Followers 6
Posts 827
Boards Moderated 0
Alias Born 05/20/2016

Re: rhoyt post# 24909

Wednesday, 01/17/2018 9:17:01 PM

Wednesday, January 17, 2018 9:17:01 PM

Post# of 25284
ALYI is NOT funding LEXGD.

Overall, what I am saying is that there are a ton of red flags including the lack of recent financials (the recent filing only has financials to June of 2016). APD IS a significant company but you can't judge that on share price. If LEXGD only had one share its share price would be almost $1MM. You have to look at market cap, or even better, enterprise value which is about $37 billion for APD so no one is disputing that it is a real company. Since ALYI states that the licenses are worth $3MM but will only put 0 dollars on the balance sheet and they tend to over PR everything, I think we can safely say $3MM is the MOST they are worth (which is the current value of ALYI so nothing great there).

More importantly, ALYI is NOT funding LEXGD. As I stated, the PR says that they will TAKE the SonCav assets of LEXGD and then dividend out shares of the new ALYI sub to LEXG, ALYI (and most likely others if they say they are raising money from doing this). It does not specify what percentage of this sub LEXGD is getting and there is no sense of what it is worth (other than "some part" of something they say is worth $3MM and is on the balance sheet at 0. If current financials come out maybe we can find out what, if anything they paid). So no, Alex conned no one, other than possibly some of those on this board, to fund him (or rather, to allow him to fund with death spiral convertibles). There is no "funding" to LEXGD from ALYI spelled out in the PR - simply an exchange of assets.

Also, there is nothing deceptive about the use of APD's name. I am sure it is factual that they have sold these patent licenses. That is how ALYI is using APD's name. They do not claim that APD supports ALYI or LEXGD. Nothing to sue for or shut down. It is not cheapening APD's name.

For a productive exercise, let's both call APD investor relations and ask them about this. Specifically if they have any details about whether they have any significant licensing revenues from those 10 lithium patents exclusively licensed to ALYI in July of 2017, any information on what they got paid, and for how long the licensing period was, etc. The IR contact at APD is Simon Moore at 610-481-7461.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.